Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BARK NYSE:DAL NASDAQ:PPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBARKBARK$0.82-1.2%$0.89$0.77▼$2.56$138.72M1.881.02 million shs823,212 shsDALDelta Air Lines$58.77+1.6%$57.66$34.74▼$69.98$38.37B1.5110.39 million shs8.36 million shsPPHVanEck Pharmaceutical ETF$88.58+0.2%$87.45$77.67▼$97.86$481.88M0.72391,393 shs487,976 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBARKBARK-1.98%-6.58%+1.46%+1.31%-52.05%DALDelta Air Lines-0.85%-4.72%-3.97%+21.83%+27.66%PPHVanEck Pharmaceutical ETF+0.16%-1.03%+1.22%+0.71%-10.05%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBARKBARK$0.82-1.2%$0.89$0.77▼$2.56$138.72M1.881.02 million shs823,212 shsDALDelta Air Lines$58.77+1.6%$57.66$34.74▼$69.98$38.37B1.5110.39 million shs8.36 million shsPPHVanEck Pharmaceutical ETF$88.58+0.2%$87.45$77.67▼$97.86$481.88M0.72391,393 shs487,976 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBARKBARK-1.98%-6.58%+1.46%+1.31%-52.05%DALDelta Air Lines-0.85%-4.72%-3.97%+21.83%+27.66%PPHVanEck Pharmaceutical ETF+0.16%-1.03%+1.22%+0.71%-10.05%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBARKBARK 2.67Moderate Buy$2.63221.45% UpsideDALDelta Air Lines 3.00Buy$66.5613.26% UpsidePPHVanEck Pharmaceutical ETF 2.58Moderate Buy$88.58N/ACurrent Analyst Ratings BreakdownLatest PPH, DAL, EZH, BARK, and SSTY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/12/2025DALDelta Air LinesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$72.00 ➝ $85.009/10/2025DALDelta Air LinesDbs BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$55.00 ➝ $60.007/14/2025DALDelta Air LinesJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$56.00 ➝ $62.007/14/2025DALDelta Air LinesWolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price Target$56.00 ➝ $63.007/14/2025DALDelta Air LinesTD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$55.00 ➝ $66.007/11/2025DALDelta Air LinesUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$72.007/11/2025DALDelta Air LinesSusquehannaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetPositive$65.007/11/2025DALDelta Air LinesSanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform7/11/2025DALDelta Air LinesBNP Paribas ExaneSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$58.00 ➝ $70.007/11/2025DALDelta Air LinesBernstein BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$60.00 ➝ $66.00(Data available from 9/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBARKBARK$484.18M0.29N/AN/A$0.57 per share1.43DALDelta Air Lines$61.64B0.62$10.13 per share5.80$23.70 per share2.48PPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBARKBARK-$32.88M-$0.17N/AN/AN/A-6.34%-15.32%-5.91%11/6/2025 (Estimated)DALDelta Air Lines$3.46B$6.908.527.101.817.24%24.86%5.01%10/9/2025 (Estimated)PPHVanEck Pharmaceutical ETFN/AN/A20.21∞N/AN/AN/AN/AN/ALatest PPH, DAL, EZH, BARK, and SSTY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/9/2025Q3 2025DALDelta Air Lines$1.48N/AN/AN/A$15.79 billionN/A7/10/2025Q2 2025DALDelta Air Lines$2.01$2.10+$0.09$3.27$16.16 billion$15.51 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBARKBARKN/AN/AN/AN/AN/ADALDelta Air Lines$0.751.28%N/A10.87%1 YearsPPHVanEck Pharmaceutical ETF$1.952.20%N/AN/AN/ALatest PPH, DAL, EZH, BARK, and SSTY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/18/2025DALDelta Air Linesquarterly$0.18751.58%7/31/20257/31/20258/21/20256/30/2025PPHVanEck Pharmaceutical ETFQuarterly$0.60692.75%7/1/20257/1/20257/7/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBARKBARKN/A1.550.79DALDelta Air Lines0.740.380.33PPHVanEck Pharmaceutical ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBARKBARK28.76%DALDelta Air Lines69.93%PPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipBARKBARK14.80%DALDelta Air Lines0.96%PPHVanEck Pharmaceutical ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBARKBARK640169.88 million144.74 millionOptionableDALDelta Air Lines100,000652.95 million646.68 millionOptionablePPHVanEck Pharmaceutical ETF147,0005.44 millionN/AOptionablePPH, DAL, EZH, BARK, and SSTY HeadlinesRecent News About These CompaniesMarkets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff BlitzAugust 9, 2025 | moneymorning.comMShould You Invest in the VanEck Pharmaceutical ETF (PPH)?July 22, 2025 | zacks.comJ&J rallies big pharma after earnings despite Trump’s latest tariff threatJuly 16, 2025 | msn.comPPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And CenterJuly 7, 2025 | seekingalpha.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6069July 1, 2025 | msn.comGlobal pharma stocks down as Trump renews tariff threatJune 17, 2025 | msn.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?May 21, 2025 | zacks.comPPH, Big Pharma Stocks Volatile on Trump Drug PricingMay 14, 2025 | finance.yahoo.comETFs on the Move Post U.S.-China Trade DealMay 12, 2025 | zacks.comA Look at Pharma ETFs After Strong Q1 EarningsMay 8, 2025 | zacks.comPPH: Will Overcome Tariffs, But Competitor Funds Look StrongerApril 14, 2025 | seekingalpha.comBig Pharma higher after tariff exemption despite ongoing uncertaintiesApril 3, 2025 | msn.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?March 20, 2025 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?January 16, 2025 | zacks.com(PPH) Investment ReportJanuary 6, 2025 | news.stocktradersdaily.comNVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.4110December 27, 2024 | msn.comPPH Is a Pertinent Healthcare Idea for 2025December 19, 2024 | etftrends.comE(PPH) Pivots Trading Plans and Risk ControlsDecember 16, 2024 | news.stocktradersdaily.comNWhen the Price of (PPH) Talks, People ListenDecember 6, 2024 | news.stocktradersdaily.comNShould You Invest in the VanEck Pharmaceutical ETF (PPH)?November 11, 2024 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePPH, DAL, EZH, BARK, and SSTY Company DescriptionsBARK NYSE:BARK$0.82 -0.01 (-1.19%) Closing price 03:59 PM EasternExtended Trading$0.84 +0.02 (+2.38%) As of 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BARK Inc., a dog-centric company, provides products, services, and content for dogs. It operates in two segments, Direct to Consumer and Commerce. The company serves dogs through monthly subscription services. It is also involved in the design of playstyle-specific toys, satisfying treats, personal meal plans with supplements, and dog-first experiences designed to foster health and happiness of dogs everywhere. In addition, the company offers monthly themed box of toys and treats under the BarkBox and Super Chewer names; personalized meal plans under the BARK Food name; health and wellness products under the BARK Bright name; and dog beds, bowls, collars, harnesses, and leashes under the BARK Home brand. Further, the company sells BARK Home products through BarkShop.com. Additionally, it offers custom collections through online marketplaces, and brick and mortar retailers. The company was formerly known as The Original BARK Company and changed its name to BARK, Inc. in November 2021. BARK Inc. was incorporated in 2011 and is headquartered in New York, New York.Delta Air Lines NYSE:DAL$58.77 +0.91 (+1.57%) Closing price 03:59 PM EasternExtended Trading$58.97 +0.20 (+0.34%) As of 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its domestic network centered on core hubs in Atlanta, Minneapolis-St. Paul, Detroit, and Salt Lake City, as well as coastal hub positions in Boston, Los Angeles, New York-LaGuardia, New York-JFK, and Seattle; and international network centered on hubs and market presence in Amsterdam, Bogota, Lima, Mexico City, London-Heathrow, Paris-Charles de Gaulle, Sao Paulo, Seoul-Incheon, and Tokyo. The company sells its tickets through various distribution channels, including delta.com and the Fly Delta app; acts as a reservations specialists; and operates online travel and traditional brick and mortar agencies. It also provides aircraft maintenance and engineering support, repair, and overhaul services; and vacation packages to third-party consumers. The company operates through a fleet of approximately 1,273 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is based in Atlanta, Georgia.VanEck Pharmaceutical ETF NASDAQ:PPH$88.58 +0.16 (+0.18%) Closing price 04:00 PM EasternExtended Trading$88.60 +0.02 (+0.02%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing? Broadcom Hits Record High After CEO Hock Tan AI Pay Package CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors Resideo Technologies: Institutional Activity Signals 30% Upside This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge Rezolute Stock: FDA Fast Track Fuels 2025 Breakout Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
